Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Among the IFN-inducible PYHIN-200 gene family, Interferon-inducible protein 16 (IFI16) exerts its multiple functions via binding to various target proteins. Thus, it has been found that IFI16 is implicated with a panel of biological activities such as antiviral immunity, inflammation, cell death and cell cycle control.
IFI16 biological functions
Figure 1. Biological functions of IFI16.
IFI16 has been demonstrated to be a DNA sensor, which stimulates type I IFN expression upon sensing of intracellular DNA. In addition to DNA sensor, IFI16 also has wide functions range gene transcriptional regulation, chromatin remodeling, from antiviral restriction and extracellular signaling regulation (Figure 1). It has been shown that IFI16 exerts its pleiotropic functions through two major domains, one is PYRIN domain involved in homotypic protein–protein interactions and another is HIN domains mediating DNA binding. Studies have reported that the binding of IFI16 to synthetic DNA is essential for DNA-stimulated nuclear translocation of interferon regulatory factor 3 (IRF3) and NF-kB and expression of IFNβ. Besides, the interaction of IFI16 with STING directly, leading to recruitment of TANK-binding kinase 1 (TBK1), is also been demonstrated. Moreover, all these molecules above are found to play important roles in induction of IFN responses during infection with a variety of pathogens, as well as in DNA damage response. However, the detail functions of IFI16 serves as a DNA sensor still remain more investigation.
Moreover, a series of studies have demonstrated that IFI16 also acts on inflammasome activation during virus infection such as herpes simplex virus 1(HSV-1), kaposi's sarcoma-associated herpes virus (KSHV), Epstein–Barr virus (EB). Besides, accumulation studies have described IFI16 as a transcriptional regulator due to the fact that overexpression of IFI16 leads to substantial inflammatory genes expression and some specific genes inhibition. Thus, IFI16 is a gene regulator in both positive and negative regulation. It has been proposed that IFI16 exerts its function on gene regulation via the specified proteins in the promoter regions since the interaction of IFI16 and DNA is not dependent on specific sequence.
IFI16 and antiviral response
Figure 2. Critical steps for IFI16-mediated control of Herpesvirus infections. (Dell'Oste V, et al. 2015)
Recently, it has been widely accepted that IFI16 serves as a restriction factor against virus infection. However, most viruses have evolved mechanisms to antagonize IFI16, contributing to their immune evasion. Herpesvirus family is illustrated for example (Figure 2). It has been shown that IFI16 recognizes the HSV-1 genome in the nucleus, then forms a functional inflammasome complex in cytoplasm with the apoptosis-associated speck-like protein containing a CARD (ASC) and procaspase-1 (proCasp-1), cleaving and activating caspase-1 (Casp-1) and IL-1β. The migration of IFI16 has been reported to stimulate the nuclear-to-cytoplasmic signaling cascade, activating IRF-3 to promote the expression of IFN type I. Nevertheless, several reports have found the fact HSV-1 utilizes its immediate-early protein ICP0 to target IFI16 for degradation, preventing the cell from inducing IFN expression and silencing the viral genome. Additionally, IFI16 also detects HCMV-DNA and exerts its antiviral function via repressing virus replication by blocking the activity of SP1 like transcription factors on the UL54 promoter of the virus, as well as activating STING-mediated antiviral cytokine expression. It has been found that human cytomegalovirus (HCMV) antagonizes IFI16 via two major aspects. On the one hand, viral protein pUL83 directly binds to IFI16, preventing IFI16 oligomerization by on DNA. On the other hand, viral kinase pUL97 binds to IFI16 and localizes IFI16 to cytoplasm, leading to IFI16 phosphorylation in vitro. Moreover, the antiviral strategies of IFI16 on KHSV and EBV are forming a functional inflammasome which is similar to HSV-1.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.